SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-018806
Filing Date
2023-05-08
Accepted
2023-05-08 16:10:23
Documents
62
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sndx-20230331.htm   iXBRL 10-Q 2049918
2 EX-10.2 sndx-ex10_2.htm EX-10 97063
3 EX-31.1 sndx-ex31_1.htm EX-31 17294
4 EX-31.2 sndx-ex31_2.htm EX-31 17703
5 EX-32.1 sndx-ex32_1.htm EX-32 17757
  Complete submission text file 0000950170-23-018806.txt   8125502

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sndx-20230331_def.xml EX-101.DEF 199423
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sndx-20230331.xsd EX-101.SCH 54648
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sndx-20230331_pre.xml EX-101.PRE 310301
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sndx-20230331_lab.xml EX-101.LAB 409588
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sndx-20230331_cal.xml EX-101.CAL 45464
56 EXTRACTED XBRL INSTANCE DOCUMENT sndx-20230331_htm.xml XML 1659366
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37708 | Film No.: 23897824
SIC: 2834 Pharmaceutical Preparations